Global Information
회사소개 | 문의 | 비교리스트

종양학 방사성 의약품 시장 : 검사 유형, 투여 경로, 용도, 최종사용자, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년)

Oncology Radiopharmaceuticals Market, by Test Type, by Route of Administration, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

리서치사 Coherent Market Insights
발행일 2021년 12월 상품코드 1045548
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,500 ₩ 5,733,000 PDF (Single User License)
US $ 7,000 ₩ 8,919,000 PDF (Multi User License)
US $ 10,000 ₩ 12,742,000 PDF (Enterprise User License)


종양학 방사성 의약품 시장 : 검사 유형, 투여 경로, 용도, 최종사용자, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년) Oncology Radiopharmaceuticals Market, by Test Type, by Route of Administration, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
발행일 : 2021년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

종양학 방사성 의약품 시장은 규제기관으로부터의 약제 승인 건수 증가, 시장 진출 기업의 무기적인 성장 전략 증가에 의해 예측기간 중 성장이 가속화될 것으로 예측됩니다.

세계의 종양학 방사성 의약품(Oncology Radiopharmaceuticals) 시장에 대해 조사했으며, 시장 역학, 기술 및 개발, 제품 발매, 부문/지역별 시장 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 개요

  • 보고서 개요
  • 개요
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • 영향 분석
  • 중요 개발
  • 시장 동향
  • 기술 상황
  • 새로운 디바이스/제품 발매
  • PEST 분석
  • Porter의 산업 분석

제4장 COVID-19의 영향 분석

  • COVID-19에 대항하기 위한 정부 이니셔티브
  • 헬스케어 시장 전체에 대한 영향
  • 수요 및 공급 분석

제5장 세계의 종양학 방사성 의약품 시장 : 유형별(2017-2028년, 금액)

  • 서론
  • Radium-223 dichloride
  • Sodium iodide I-131
  • Lobenguane iodine-131
  • Lutetium-177
  • Yttrium-90
  • Fludeoxyglucose F 18
  • Gallium Citrate Ga 67
  • Technetium-99m
  • 기타

제6장 세계의 종양학 방사성 의약품 시장 : 투여 경로별(2017-2028년, 금액)

  • 서론
  • 경구
  • 정맥내

제7장 세계의 종양학 방사성 의약품 시장 : 용도별(2017-2028년, 금액)

  • 서론
  • 치료
  • 진단

제8장 세계의 종양학 방사성 의약품 시장 : 최종사용자별(2017-2028년, 금액)

  • 서론
  • 진단센터
  • 병원/클리닉
  • 연구

제9장 세계의 종양학 방사성 의약품 시장 : 지역별(2017-2028년, 금액)

  • 서론
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제10장 경쟁 구도

  • 기업 개요
    • Siemens Healthcare GmbH
    • Novartis AG
    • Curium
    • GE Healthcare
    • Lantheus Medical Imaging, Inc.
    • International Isotopes, Inc.
    • Nordion
    • Eckert &Zieger
    • Acrotech Biopharma
    • Blue Earth Diagnostics
    • Zionexa
    • Bayer AG
    • Jubilant Pharma Limited
    • Cardinal Health
  • 애널리스트의 견해

제11장 섹션

LSH 22.02.17

Radiopharmaceuticals are medications that contain radioactive (isotopes), which are used for the treatment or diagnose of cancer. These medications can be administered into patient's body orally, intravenously or interstitially (inserted into a cavity in the body). Radiopharmaceuticals are inserted into the body and when it reaches the targeted area of the body, it releases radioactive agents to destroy the tumor cells. Fludeoxyglucose F 18, Gallium Citrate Ga 67, Indium In 111 Pentetreotide, Methionine C 11, Radioiodinated Iobenguane, Sodium Fluoride F 18, Technetium Tc 99m Arcitumomab, Technetium Tc 99m Nofetumomab Merpentan are the oral radiopharmaceuticals used in the diagnosis of cancer

Radiopharmaceuticals can be used to treat following cancers:

  • Thyroid cancer
  • Brain cancer
  • Lymphoma
  • Cancers that have spread to the bones

Market Dynamics

Increasing number of drug approvals from regulatory bodies is expected to drive the growth of the global oncology radiopharmaceutical market during the forecast period. For instance, in May 2020, PETNET Solutions, Inc., a Siemens Healthineers company, and Zionexa USA, a wholly-owned subsidiary of Zionexa SAS, announced that the U.S. Food and Drug Administration (FDA) approved Cerianna (fluoroestradiol F 18) injection for intravenous use. Cerianna (fluoroestradiol F 18) is the first FDA-approved F-18 PET imaging agent specifically indicated for use in patients with recurrent or metastatic breast cancer.

Increasing number of inorganic growth strategies by market players is expected to drive the growth of global oncology radiopharmaceuticals market. For instance, in June 2021, Bayer AG a pharmaceuticals and life science company announced that the company signed an agreement to acquire Noria Therapeutics Inc. and PSMA Therapeutics Inc. Noria Therapeutics Inc is a radiotherapy company developing targeted therapeutic and imaging radiopharmaceuticals. This acquisition will provide rights to Bayer to differentiate alpha radionuclide therapy based on actinium-225 and a small molecule targeting prostate-specific membrane antigen (PSMA).

Key features of the study:

  • This report provides an in-depth analysis of the global oncology radiopharmaceutical market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global oncology radiopharmaceutical market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include Siemens Healthcare GmbH, Novartis AG, Curium, GE Healthcare, Lantheus Medical Imaging, Inc., International Isotopes, Inc., Nordion, Eckert & Zieger, Acrotech Biopharma, Blue Earth Diagnostics, Zionexa, Bayer AG, Jubilant Pharma Limited, and Cardinal Health
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global oncology radiopharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global oncology radiopharmaceutical market

Detailed Segmentation:

  • Global Oncology Radiopharmaceutical Market, By Type:
    • Radium-223 dichloride
    • Sodium iodide I-131
    • Lobenguane iodine-131
    • Lutetium-177
    • Yttrium-90
    • Fludeoxyglucose F 18
    • Gallium Citrate Ga 67
    • Technetium-99m
    • Others
  • Global Oncology Radiopharmaceutical Market, By Route of Administration:
    • Oral
    • Intravenous
  • Global Oncology Radiopharmaceutical Market, By Application:
    • Treatment
    • Diagnosis
  • Global Oncology Radiopharmaceutical Market, By End User:
    • Diagnostic Centers
    • Hospitals and Clinics
    • Cancer Research Institutes
  • Global Oncology Radiopharmaceutical Market, By Region:
    • North America
  • By Type:
    • Radium-223 dichloride
    • Sodium iodide I-131
    • Lobenguane iodine-131
    • Lutetium-177
    • Yttrium-90
    • Fludeoxyglucose F 18
    • Gallium Citrate Ga 67
    • Technetium-99m
    • Others
  • By Route of Administration:
    • Oral
    • Intravenous
  • By Application:
    • Treatment
    • Diagnosis
  • By End User:
    • Diagnostic Centers
    • Hospitals and Clinics
    • Cancer Research Institute
  • By Country:
    • U.S.
    • Canada
    • Latin America
  • By Type:
    • Radium-223 dichloride
    • Sodium iodide I-131
    • Lobenguane iodine-131
    • Lutetium-177
    • Yttrium-90
    • Fludeoxyglucose F 18
    • Gallium Citrate Ga 67
    • Technetium-99m
    • Others
  • By Route of Administration:
    • Oral
    • Intravenous
  • By Application:
    • Treatment
    • Diagnosis
  • By End User:
    • Diagnostic Centers
    • Hospitals and Clinics
    • Cancer Research Institute
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • By Type:
    • Radium-223 dichloride
    • Sodium iodide I-131
    • Lobenguane iodine-131
    • Lutetium-177
    • Yttrium-90
    • Fludeoxyglucose F 18
    • Gallium Citrate Ga 67
    • Technetium-99m
    • Others
  • By Route of Administration:
    • Oral
    • Intravenous
  • By Application:
    • Treatment
    • Diagnosis
  • By End User:
    • Diagnostic Centers
    • Hospitals and Clinics
    • Cancer Research Institute
  • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Type:
    • Radium-223 dichloride
    • Sodium iodide I-131
    • Lobenguane iodine-131
    • Lutetium-177
    • Yttrium-90
    • Fludeoxyglucose F 18
    • Gallium Citrate Ga 67
    • Technetium-99m
    • Others
  • By Route of Administration:
    • Oral
    • Intravenous
  • By Application:
    • Treatment
    • Diagnosis
  • By End User:
    • Diagnostic Centers
    • Hospitals and Clinics
    • Cancer Research Institute
  • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
  • By Type:
    • Radium-223 dichloride
    • Sodium iodide I-131
    • Lobenguane iodine-131
    • Lutetium-177
    • Yttrium-90
    • Fludeoxyglucose F 18
    • Gallium Citrate Ga 67
    • Technetium-99m
    • Others
  • By Route of Administration:
    • Oral
    • Intravenous
  • By Application:
    • Treatment
    • Diagnosis
  • By End User:
    • Diagnostic Centers
    • Hospitals and Clinics
    • Cancer Research Institute
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Type:
    • Radium-223 dichloride
    • Sodium iodide I-131
    • Lobenguane iodine-131
    • Lutetium-177
    • Yttrium-90
    • Fludeoxyglucose F 18
    • Gallium Citrate Ga 67
    • Technetium-99m
    • Others
  • By Route of Administration:
    • Oral
    • Intravenous
  • By Application:
    • Treatment
    • Diagnosis
  • By End User:
    • Diagnostic Centers
    • Hospitals and Clinics
    • Cancer Research Institute
  • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
  • Siemens Healthcare GmbH *
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Novartis AG
  • Curium
  • GE Healthcare
  • Lantheus Medical Imaging, Inc.
  • International Isotopes, Inc.
  • Nordion
  • Eckert & Zieger
  • Acrotech Biopharma
  • Blue Earth Diagnostics
  • Zionexa
  • Bayer AG
  • Jubilant Pharma Limited
  • Cardinal Health

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Development
  • Market Trends
  • Technology Landscape
  • New Device/Product Launches
  • PEST Analysis
  • Porter's Five Forces Analysis

4. COVID - 19 Impact Analysis

  • Government Initiative to Combat Covid-19
  • Impact on Overall Healthcare Market
  • Demand and Supply Analysis

5. Global Oncology Radiopharmaceuticals Market, By Type, 2017-2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Radium-223 dichloride
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Sodium iodide I-131
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Lobenguane iodine-131
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Lutetium-177
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Yttrium-90
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Fludeoxyglucose F 18
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Gallium Citrate Ga 67
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Technetium-99m
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Oncology Radiopharmaceuticals Market, By Route of Administration, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Oncology Radiopharmaceuticals Market, By Application, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Oncology Radiopharmaceuticals Market, By End User, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Research Institute
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

9. Global Oncology Radiopharmaceuticals Market, By Region, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Landscape

  • Company Profiles
    • Siemens Healthcare GmbH
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Curium
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • GE Healthcare
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Lantheus Medical Imaging, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • International Isotopes, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Nordion
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Eckert & Zieger
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Acrotech Biopharma
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Blue Earth Diagnostics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Zionexa
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Bayer AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Jubilant Pharma Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Cardinal Health
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q